H.Amdt. 323House118th Congress (2023-2025)

An amendment numbered 68 printed in Part F of House Report 118-216 to prohibit funds from being used to continue implementing the the FDA's 2006 and 2011 Compliance Policy guide which created the Unapproved Drugs Initiative.

Submitted September 26, 2023

Legislative Activity

Stay on top of the latest movement without scrolling through every action

5 earlier actions
Floor Latest Action

House amendment agreed to: On agreeing to the McCormick amendment (A020) Agreed to by voice vote.

September 26, 2023 • 11:47 PM

View full timeline
Floor

House amendment agreed to: On agreeing to the McCormick amendment (A020) Agreed to by voice vote.

September 26, 2023 • 11:47 PM

Floor

House amendment offered

September 26, 2023

Floor

House amendment agreed to: On agreeing to the McCormick amendment (A020) Agreed to by voice vote.

September 26, 2023 • 11:47 PM

Floor

House Amendment Offered

September 26, 2023 • 11:44 PM

Floor

Amendment (A020) offered by Mr. McCormick. (consideration: CR H4542; text: CR H4542)

September 26, 2023 • 11:44 PM

Floor

On agreeing to the McCormick amendment (A020) Agreed to by voice vote.

September 26, 2023 • 11:47 PM

Text

Offered

Plain text for this version is not available yet.